179 related articles for article (PubMed ID: 29706522)
1. The association between diabetes, comorbidities, body mass index and all-cause and cause-specific mortality among women with endometrial cancer.
Nagle CM; Crosbie EJ; Brand A; Obermair A; Oehler MK; Quinn M; Leung Y; Spurdle AB; Webb PM;
Gynecol Oncol; 2018 Jul; 150(1):99-105. PubMed ID: 29706522
[TBL] [Abstract][Full Text] [Related]
2. Body mass index, diabetes and survival after diagnosis of endometrial cancer: A report from the HUNT-Survey.
Lindemann K; Cvancarova M; Eskild A
Gynecol Oncol; 2015 Dec; 139(3):476-80. PubMed ID: 26434365
[TBL] [Abstract][Full Text] [Related]
3. The prognostic significance of aortic lymph node metastasis in endometrial cancer: Potential implications for selective aortic lymph node assessment.
Cosgrove CM; Cohn DE; Rhoades J; Felix AS
Gynecol Oncol; 2019 Jun; 153(3):505-510. PubMed ID: 30935714
[TBL] [Abstract][Full Text] [Related]
4. Cardiometabolic risk factors and survival after cancer in the Women's Health Initiative.
Simon MS; Hastert TA; Barac A; Banack HR; Caan BJ; Chlebowski RT; Foraker R; Hovsepyan G; Liu S; Luo J; Manson JE; Neuhouser ML; Okwuosa TM; Pan K; Qi L; Ruterbusch JJ; Shadyab AH; Thomson CA; Wactawski-Wende J; Waheed N; Beebe-Dimmer JL
Cancer; 2021 Feb; 127(4):598-608. PubMed ID: 33151547
[TBL] [Abstract][Full Text] [Related]
5. Cause-specific mortality in endometrioid endometrial cancer patients with type 2 diabetes using metformin or other types of antidiabetic medication.
Arima R; Hautakoski A; Marttila M; Arffman M; Sund R; Ilanne-Parikka P; Kangaskokko J; Hinkula M; Puistola U; Läärä E
Gynecol Oncol; 2017 Dec; 147(3):678-683. PubMed ID: 29054569
[TBL] [Abstract][Full Text] [Related]
6. Prediagnosis body mass index, physical activity, and mortality in endometrial cancer patients.
Arem H; Park Y; Pelser C; Ballard-Barbash R; Irwin ML; Hollenbeck A; Gierach GL; Brinton LA; Pfeiffer RM; Matthews CE
J Natl Cancer Inst; 2013 Mar; 105(5):342-9. PubMed ID: 23297041
[TBL] [Abstract][Full Text] [Related]
7. Post-diagnosis body mass index and mortality among women diagnosed with endometrial cancer: Results from the Women's Health Initiative.
Arem H; Pfeiffer RM; Moore SC; Irwin ML; LaMonte MJ; Sarto GE; Nassir R; Luo J; Chlebowski RT; Brinton LA; Matthews CE
PLoS One; 2017; 12(2):e0171250. PubMed ID: 28152055
[TBL] [Abstract][Full Text] [Related]
8. Antidiabetic Medication, Statins and the Risk and Prognosis of Non-endometrioid Endometrial Cancer in Women with Type 2 Diabetes.
Arima R; Marttila M; Hautakoski A; Arffman M; Sund R; Ilanne-Parikka P; Kangaskokko J; Urpilainen E; Läärä E; Hinkula M; Puistola U
Anticancer Res; 2018 Jul; 38(7):4169-4178. PubMed ID: 29970546
[TBL] [Abstract][Full Text] [Related]
9. Body mass index, physical activity, and television time in relation to mortality risk among endometrial cancer survivors in the NIH-AARP Diet and Health Study cohort.
Arem H; Pfeiffer RM; Moore SC; Brinton LA; Matthews CE
Cancer Causes Control; 2016 Nov; 27(11):1403-1409. PubMed ID: 27730319
[TBL] [Abstract][Full Text] [Related]
10. Metformin use and endometrial cancer survival.
Nevadunsky NS; Van Arsdale A; Strickler HD; Moadel A; Kaur G; Frimer M; Conroy E; Goldberg GL; Einstein MH
Gynecol Oncol; 2014 Jan; 132(1):236-40. PubMed ID: 24189334
[TBL] [Abstract][Full Text] [Related]
11. Guideline-concordant treatment is associated with improved survival among women with non-endometrioid endometrial cancer.
Dholakia J; Llamocca E; Quick A; Salani R; Felix AS
Gynecol Oncol; 2020 Jun; 157(3):716-722. PubMed ID: 32217002
[TBL] [Abstract][Full Text] [Related]
12. Obesity, diabetes, and other factors in relation to survival after endometrial cancer diagnosis.
Chia VM; Newcomb PA; Trentham-Dietz A; Hampton JM
Int J Gynecol Cancer; 2007; 17(2):441-6. PubMed ID: 17362320
[TBL] [Abstract][Full Text] [Related]
13. [Clinical application of adult comorbidity evaluation-27 in endometrial cancer].
Tian WY; Wang YM; Yan Y; Gao JP; Sun DD; Jiang S; Sheng Y; Teng F; Xue FX
Zhonghua Fu Chan Ke Za Zhi; 2016 Nov; 51(11):810-817. PubMed ID: 27916063
[No Abstract] [Full Text] [Related]
14. Risk of cardiovascular disease among women with endometrial cancer compared to cancer-free women in the Women's Health Initiative.
Felix AS; Lehman A; Foraker RE; Naughton MJ; Bower JK; Kuller L; Sarto GE; Stefanick ML; Van Horn L; Jackson RD; Paskett ED
Cancer Epidemiol; 2017 Dec; 51():62-67. PubMed ID: 29049937
[TBL] [Abstract][Full Text] [Related]
15. Endometrial cancer risk and survival by tumor MMR status.
Nagle CM; O'Mara TA; Tan Y; Buchanan DD; Obermair A; Blomfield P; Quinn MA; Webb PM; Spurdle AB;
J Gynecol Oncol; 2018 May; 29(3):e39. PubMed ID: 29533022
[TBL] [Abstract][Full Text] [Related]
16. Cardiovascular disease mortality among women with endometrial cancer in the Iowa Women's Health Study.
Felix AS; Blair CK; Lehman A; Bower JK; Raman SV; Lazovich D; Cohn DE; Prizment AE
Cancer Causes Control; 2017 Oct; 28(10):1043-1051. PubMed ID: 28864924
[TBL] [Abstract][Full Text] [Related]
17. Guideline-concordant endometrial cancer treatment and survival in the Women's Health Initiative Life and Longevity After Cancer study.
Felix AS; McLaughlin EM; Caan BJ; Cohn DE; Anderson GL; Paskett ED
Int J Cancer; 2020 Jul; 147(2):404-412. PubMed ID: 31618444
[TBL] [Abstract][Full Text] [Related]
18. Adult Comorbidity Evaluation 27 score as a predictor of survival in endometrial cancer patients.
Binder PS; Peipert JF; Kallogjeri D; Brooks RA; Massad LS; Mutch DG; Powell MA; Thaker PH; McCourt CK
Am J Obstet Gynecol; 2016 Dec; 215(6):766.e1-766.e9. PubMed ID: 27457116
[TBL] [Abstract][Full Text] [Related]
19. Body mass index, physical activity, and survival after endometrial cancer diagnosis: results from the Women's Health Initiative.
Arem H; Chlebowski R; Stefanick ML; Anderson G; Wactawski-Wende J; Sims S; Gunter MJ; Irwin ML
Gynecol Oncol; 2013 Feb; 128(2):181-6. PubMed ID: 23127972
[TBL] [Abstract][Full Text] [Related]
20. Lymphadenectomy in Early-Stage Intermediate-/High-Risk Endometrioid Endometrial Cancer: Clinical Characteristics and Outcomes in an Australian Cohort.
Farrell R; Dixon SC; Carter J; Webb PM
Int J Gynecol Cancer; 2017 Sep; 27(7):1379-1386. PubMed ID: 30814240
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
